Lasa Supergenerics Files SDD Compliance Certificate for Q1 FY27
Lasa Supergenerics Limited submitted its SDD Compliance Certificate for the quarter ended June 30, 2026. The company confirmed it has a functional, secure, and non-tamperable Structured Digital Database in place, capturing all UPSI as per SEBI regulations. No non-compliance was reported.
This is a standard regulatory filing, indicating compliance with SEBI's insider trading regulations. It does not introduce any new material information that would directly affect the company's operations, financials, or stock price.
The announcement is a routine compliance filing and does not contain any new financial information or strategic developments that would significantly impact the company's outlook.
Lasa Supergenerics Limited has submitted its Structured Digital Database (SDD) Compliance Certificate for the quarter ended June 30, 2026, to the BSE and NSE. The certificate, issued in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, confirms the company's adherence to insider trading norms.
The Compliance Officer, Mitti Jain, certified that the company maintains a functional SDD with controlled access, capturing all Unpublished Price Sensitive Information (UPSI) disseminated during the quarter, along with its nature, date, and time. The database is maintained internally with an audit trail, is non-tamperable, and capable of retaining records for eight years. The company successfully captured two required events during the quarter, with no non-compliance reported from the previous quarter.
Omkar Herlekar, Chairman and Managing Director, signed off on the submission, reinforcing the company's commitment to regulatory compliance.
What to do with a filing like this
Lasa Supergenerics Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lasa Supergenerics Limited. Read the original for the full detail.